Ligand Pharmaceuticals prices \$400 million convertible notes to support strategic growth, strengthen balance sheet, and pursue potential acquisition opportunities. #LigandPharma #ConvertibleNotes #BiotechFinance https://meyka.com/blog/ligand-pharmaceuticals-announces-400-million-convertible-notes-pricing/

Astral shares drop 6% after Q1 profit after tax declines 33% year-on-year, raising investor concerns over earnings outlook. \#Astral #StockMarket #EarningsReport https://meyka.com/blog/astral-shares-fall-6-as-q1-profit-after-tax-drops-33-yoy/

Barclays shares soar 72%, sparking investor debate on future growth potential and market risks. Is this the moment to invest? #BarclaysStock #InvestingNews #MarketTrends https://meyka.com/blog/barclays-shares-is-now-the-right-time-to-buy-after-a-72-surge/

AMC stock surges after unexpected revenue beat, fueled by strong movie attendance and renewed investor optimism. #AMCStock #StockMarket #Investing https://meyka.com/blog/amc-stock-rockets-after-surprise-revenue-beat-whats-driving-the-rally/

Macerich’s \$130M Crabtree acquisition boosts SNO pipeline, driving strong retail and industrial growth across expanding market opportunities. #Macerich #RetailGrowth #IndustrialExpansion https://meyka.com/blog/crabtree-acquisition-how-macerichs-130m-sno-pipeline-fuels-retail-industrial-growth/

Tesla shares surge 9.6% after Texas robotaxi approval and UK energy license bid, sparking investor excitement and market optimism. #Tesla #StockMarket #Robotaxi https://meyka.com/blog/tesla-stock-jumps-9-6-after-robotaxi-approval-in-texas-and-uk-energy-license-bid/